Organon Predicts Implanon Launch In 2005 Following "Approvable" Letter

The company expects to introduce the contraceptive sub-dermal implant in the first half of the year. In deeming Implanon "approvable," FDA did not request additional trials, Organon says. The product is expected to carry a maximum three-year indication upon approval.